Google DeepMind and Isomorphic Labs share bioresilience approach

Google DeepMind and Isomorphic Labs have outlined their joint strategy to enhance global biosecurity by leveraging AI to prevent misuse, detect outbreaks, and respond to biological threats. The companies emphasize the need for frontier AI models to help society build resilience against future pandemics and safety risks.

• The organizations have advanced more than 15 partnerships with government bodies and research groups over the past 12 months.
• They utilize tools like AlphaFold, the IsoDDE drug design engine, and AlphaGenome to accelerate therapeutic discovery and understand genome function.
• SynthID watermarking technology is being adapted for biology to help DNA synthesis providers screen for risky AI-generated sequences.
• The AlphaEvolve agent optimizes metagenomic sequencing algorithms to make pathogen surveillance more cost-effective and faster.
• Isomorphic Labs established a focused unit to rapidly deploy its drug design engine for governments and non-profits during novel outbreaks.

This effort aligns with the Frontier Safety Framework's protocols, aiming to ensure AI is developed responsibly to protect against Chemical, Biological, Radiological and Nuclear (CBRN) risks.